Therapeutic pipeline in nonalcoholic steatohepatitis – Nature Reviews Gastroenterology & Hepatology
The therapeutic pipeline for nonalcoholic steatohepatitis (NASH) is expanding as insights into disease pathophysiology are gained. This Review summarizes progress in the development of NASH therapies, current and ongoing clinical trials, and potential challenges with emerging therapies.